LeadStory

CBC News

Ozempic, Mounjaro linked to vision loss in diabetics

CBC News · 28 days ago
CBC News
CBC News
28 days ago

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the risk of a severe form of vision loss among diabetics, affecting daily activities such as reading and driving.

BreakdownGenerated by LeadStory AI
  • GLP-1 drugs like Ozempic and Mounjaro may double the risk of a severe form of vision loss in diabetics. 15s
  • The study reviewed health records of nearly 140,000 older adults with diabetes. 35s
  • The absolute risk remains low: two in a thousand for GLP-1 users versus one in a thousand for non-users. 45s
  • Doctors generally believe the benefits of GLP-1 drugs outweigh the risks for most patients. 1m 7s
  • Some doctors may reconsider prescribing GLP-1 drugs to patients with pre-existing eye disease or advise them to monitor vision changes. 1m 41s
HealthMedical Research